Literature DB >> 25124781

A common progenitor cell in LCH and ECD.

Gayane Badalian-Very1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25124781      PMCID： PMC4133500          DOI： 10.1182/blood-2014-06-581736

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.

Authors:  Julien Haroche; Frédéric Charlotte; Laurent Arnaud; Andreas von Deimling; Zofia Hélias-Rodzewicz; Baptiste Hervier; Fleur Cohen-Aubart; David Launay; Annette Lesot; Karima Mokhtari; Danielle Canioni; Louise Galmiche; Christian Rose; Marc Schmalzing; Sandra Croockewit; Marianne Kambouchner; Marie-Christine Copin; Sylvie Fraitag; Felix Sahm; Nicole Brousse; Zahir Amoura; Jean Donadieu; Jean-François Emile
Journal:  Blood       Date:  2012-08-09       Impact factor: 22.113

Review 2.  Pathogenesis of Langerhans cell histiocytosis.

Authors:  Gayane Badalian-Very; Jo-Anne Vergilio; Mark Fleming; Barrett J Rollins
Journal:  Annu Rev Pathol       Date:  2012-08-06       Impact factor: 23.472

3.  Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.

Authors:  Carl E Allen; Liunan Li; Tricia L Peters; Hon-Chiu Eastwood Leung; Alexander Yu; Tsz-Kwong Man; Sivashankarappa Gurusiddappa; Michelle T Phillips; M John Hicks; Amos Gaikwad; Miriam Merad; Kenneth L McClain
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

4.  Recurrent BRAF mutations in Langerhans cell histiocytosis.

Authors:  Gayane Badalian-Very; Jo-Anne Vergilio; Barbara A Degar; Laura E MacConaill; Barbara Brandner; Monica L Calicchio; Frank C Kuo; Azra H Ligon; Kristen E Stevenson; Sarah M Kehoe; Levi A Garraway; William C Hahn; Matthew Meyerson; Mark D Fleming; Barrett J Rollins
Journal:  Blood       Date:  2010-06-02       Impact factor: 22.113

Review 5.  Development of monocytes, macrophages, and dendritic cells.

Authors:  Frederic Geissmann; Markus G Manz; Steffen Jung; Michael H Sieweke; Miriam Merad; Klaus Ley
Journal:  Science       Date:  2010-02-05       Impact factor: 47.728

6.  Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation.

Authors:  Julien Haroche; Fleur Cohen-Aubart; Jean-François Emile; Laurent Arnaud; Philippe Maksud; Frédéric Charlotte; Philippe Cluzel; Aurélie Drier; Baptiste Hervier; Neïla Benameur; Sophie Besnard; Jean Donadieu; Zahir Amoura
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

7.  Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation.

Authors:  Baptiste Hervier; Julien Haroche; Laurent Arnaud; Frédéric Charlotte; Jean Donadieu; Antoine Néel; François Lifermann; Carles Villabona; Bruno Graffin; Olivier Hermine; Aude Rigolet; Camille Roubille; Eric Hachulla; Thierry Carmoi; Maud Bézier; Véronique Meignin; Marie Conrad; Laurence Marie; Elise Kostrzewa; Jean-Marie Michot; Stéphane Barete; Valerie Taly; Karine Cury; Jean-François Emile; Zahir Amoura
Journal:  Blood       Date:  2014-06-03       Impact factor: 22.113

8.  BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.

Authors:  Marie-Luise Berres; Karen Phaik Har Lim; Tricia Peters; Jeremy Price; Hitoshi Takizawa; Hélène Salmon; Juliana Idoyaga; Albert Ruzo; Philip J Lupo; M John Hicks; Albert Shih; Stephen J Simko; Harshal Abhyankar; Rikhia Chakraborty; Marylene Leboeuf; Monique Beltrão; Sérgio A Lira; Kenneth M Heym; Venetia Bigley; Matthew Collin; Markus G Manz; Kenneth McClain; Miriam Merad; Carl E Allen
Journal:  J Exp Med       Date:  2014-03-17       Impact factor: 14.307
  8 in total
  3 in total

1.  Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report.

Authors:  Seokhwi Kim; Minju Lee; Hyung Jin Shin; Joohee Lee; Yeon-Lim Suh
Journal:  Childs Nerv Syst       Date:  2015-10-14       Impact factor: 1.475

2.  Preceding polydipsia/polyuria, ataxia, and dysarthria in an adult with mixed histiocytosis (Erdheim Chester disease/Langerhans cell histiocytosis).

Authors:  Takashi Miyoshi; Shigehisa Tamaki; Ko Kudo; Fumihiko Kono; Tomoya Masada; Shinsaku Imashuku
Journal:  Ann Hematol       Date:  2022-10-05       Impact factor: 4.030

Review 3.  Personalized medicine in hematology - A landmark from bench to bed.

Authors:  Gayane Badalian-Very
Journal:  Comput Struct Biotechnol J       Date:  2014-08-08       Impact factor: 7.271
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.